1.
Haxhiu I. P080 | Targeting CK2 disrupts epigenetic plasticity and sensitizes diffuse large B-cell lymphoma cells to the EZH2 inhibitor tazemetostat: <a href="https://haematologica.org/search/search?query=I.+Haxhiu">I. Haxhiu</a><sup>1|2</sup>, <a href="https://haematologica.org/search/search?query=A.+Yami">A. Yami</a><sup>1|2|3</sup>, <a href="https://haematologica.org/search/search?query=L.+Quotti+Tubi">L. Quotti Tubi</a><sup>1|2</sup>, <a href="https://haematologica.org/search/search?query=J.+Uddin+Dekha">J. Uddin Dekha</a><sup>1|2|3</sup>, <a href="https://haematologica.org/search/search?query=J.+Ceccato">J. Ceccato</a><sup>1|2</sup>, <a href="https://haematologica.org/search/search?query=N.+Danesin">N. Danesin</a><sup>1</sup>, <a href="https://haematologica.org/search/search?query=G.+Scapinello">G. Scapinello</a><sup>1</sup>, <a href="https://haematologica.org/search/search?query=M.+Carraro">M. Carraro</a><sup>1</sup>, <a href="https://haematologica.org/search/search?query=A.+Visentin">A. Visentin</a><sup>1</sup>, <a href="https://haematologica.org/search/search?query=F.+Vianello">F. Vianello</a><sup>1|2</sup>, <a href="https://haematologica.org/search/search?query=L.+Trentin">L. Trentin</a><sup>1</sup>, <a href="https://haematologica.org/search/search?query=S.+Manni">S. Manni</a><sup>1|2</sup>, <a href="https://haematologica.org/search/search?query=F.+Piazza">F. Piazza</a><sup>1|2</sup> | <i><sup>1</sup>Hematology Unit, Department of Medicine, University of Padova; <sup>2</sup>Veneto Institute of Molecular Medicine; <sup>3</sup>Department of Surgery, Oncology and Gastroenterology, University of Padova.</i&gt;. Haematologica;111(s1):; https://doi.org/10.3324/haematol.2026.s1.142.